RaQualia Pharma (4579.T) Earnings Analysis

RaQualia Pharma (4579.T) next reports earnings on 2026-08-14. Trailing P/E 153.72.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4579.T next report earnings?

Next earnings date2026-08-14
Consensus EPS estimaten/a
Revenue estimaten/a

4579.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-8.84 JPYn/an/an/a
2026-02-1335.82 JPYn/an/an/a
2025-09-29-8.75957 JPYn/an/an/a
2025-05-15-0.24 JPYn/an/an/a
2025-02-12-7.16 JPYn/an/an/a
2024-11-14-0.74 JPYn/an/an/a
2024-08-14-11.36 JPYn/an/an/a

4579.T valuation and analyst view

Trailing P/E153.72
Trailing EPS2.062 JPY
Price / book1.44
Dividend yield0.00%
Market cap11.10B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is RaQualia Pharma (4579.T)'s next earnings date?

RaQualia Pharma is next scheduled to report on 2026-08-14.

Did 4579.T beat earnings last quarter?

Consensus estimate data was not available for 4579.T's 2026-05-15 report.

What is 4579.T's current P/E ratio and EPS?

4579.T trades at a trailing P/E of 153.72 on trailing EPS of 2.0615645519151045 JPY.

What do analysts rate 4579.T?

4579.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.